Inventor · disambiguated record
Wolin Huang
Also filed as: HUANG WOLIN · SCARBOROUGH LEGAL REPRESENTATIVE CARROLL ANNA
26 granted patents·11 pending applications·352 citations·filing 1996–2019
96Inventor score
Top patents by PatentIndex Score
37 records- 0197US8138339B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2009·Granted Mar 20, 2012·63 cites·19 claims
- 0294US8501944B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2012·Granted Aug 6, 2013·19 cites·2 claims
- 0394US8349860B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2011·Granted Jan 8, 2013·9 cites·2 claims
- 0494US8318755B2Inhibitors of SYK and JAK protein kinasesJIA ZHAOZHONG J·Filed 2011·Granted Nov 27, 2012·10 cites·2 claims
- 0594US8063058B2Inhibitors of syk and JAK protein kinasesJIA ZHAOZHONG J·Filed 2009·Granted Nov 22, 2011·14 cites·17 claims
- 0692US8952027B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2012·Granted Feb 10, 2015·6 cites·21 claims
- 0792US8853230B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2012·Granted Oct 7, 2014·19 cites·14 claims
- 0892US6906063B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2001·Granted Jun 14, 2005·34 cites·8 claims
- 0991US7022731B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2004·Granted Apr 4, 2006·22 cites·12 claims
- 1089US6689786B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2003·Granted Feb 10, 2004·24 cites·13 claims
- 1188US10533001B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2017·Granted Jan 14, 2020·4 cites·13 claims
- 1288US8367689B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2010·Granted Feb 5, 2013·11 cites·27 claims
- 1386US7358257B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·7 cites·10 claims
- 1486US7166695B2Affinity markers for human serum albuminCONJUCHEM BIOTECHNOLOGIES INC·Filed 2004·Granted Jan 23, 2007·19 cites·33 claims
- 1581US9102625B2Nicotinamides as JAK kinase modulatorsBAUER SHAWN M·Filed 2011·Granted Aug 11, 2015·5 cites·10 claims
- 1679US11414410B2Inhibitors of protein kinasesALEXION PHARMA INC·Filed 2019·Granted Aug 16, 2022·0 cites·6 claims
- 1775US6277583B1Affinity labeling libraries and applications thereofCONJUCHEM INC·Filed 1996·Granted Aug 21, 2001·49 cites·9 claims
- 1874US7056926B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2004·Granted Jun 6, 2006·4 cites·20 claims
- 1970US9579320B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Feb 28, 2017·0 cites·3 claims
- 2068US2011212983A1Platelet adp receptor inhibitorsPORTOLA PHARM INC·Filed 2009·Application pending·0 cites
- 2167US8067428B2Platelet ADP receptor inhibitorsSCARBOROUGH ROBERT M·Filed 2009·Granted Nov 29, 2011·0 cites·8 claims
- 2267US6403324B1Affinity labeling libraries with tagged leaving groupCONJUCHEM INC·Filed 1998·Granted Jun 11, 2002·32 cites·15 claims
- 2364US8058284B2[4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related theretoSCARBOROUGH ROBERT·Filed 2006·Granted Nov 15, 2011·1 cites·49 claims
- 2463US7622474B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2007·Granted Nov 24, 2009·0 cites·8 claims
- 2562US2014221405A1Platelet adp receptor inhibitorsPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 2661US7678790B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2005·Granted Mar 16, 2010·0 cites·9 claims
- 2758US8524721B2Platelet ADP receptor inhibitorsSCARBOROUGH ROBERT M·Filed 2011·Granted Sep 3, 2013·0 cites·9 claims
- 2858US2009156620A1[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related theretoPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 2957US2009048216A1Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitorPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3054US2012009172A1Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitorGRETLER DANIEL D·Filed 2011·Application pending·0 cites
- 3150US2002025961A1Platelet ADP receptor inhibitorsFiled 2001·Application pending·0 cites
- 3249US2009042916A1[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related theretoPORTOLA PHARM INC·Filed 2008·Application pending·0 cites
- 3348US7109332B22,4-dioxo-3-quinazolinylaryl sulfonylureasPORTOLA PHARM INC·Filed 2004·Granted Sep 19, 2006·0 cites·46 claims
- 3445US2012129876A1[4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related theretoSHARP EMMA·Filed 2011·Application pending·0 cites
- 3542US2015353495A1Nicotinamides as jak kinase modulatorsPORTOLA PHARM INC·Filed 2015·Application pending·0 cites
- 3639US2013317029A1Oxypyrimidines as syk modulatorsPANDEY ANJALI·Filed 2011·Application pending·0 cites
- 3737US2012088736A1[4-(6-HALO-7-Substituted-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREAS and Forms and Methods Related TheretoSCARBOROUGH ROBERT·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolin Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →